A multi-omic dissection of super-enhancer driven oncogenic gene expression programs in ovarian cancer
M. R. Kelly, K. Wisniewska, M. J. Regner, M. W. Lewis, A. A. Perreault, E. S. Davis, D. H. Phanstiel, J. S. Parker, H. L. Franco
This study identifies clinically relevant super-enhancers in ovarian cancer using multi-omic approaches and shows their role in driving oncogenic gene expression programs.
bioRxiv · Apr 8, 2022Cancer Biology